TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

120.00$ -3.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 425 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INSM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
79 84 76 90 93 104 93 107 142 264 306 425 1,138
17 18 17 21 21 26 21 28 29 44 50 67 190
62 65 58 69 72 78 72 79 113 220 256 358 947
109 137 121 147 151 180 153 177 186 255 209 210 861
91 90 93 107 119 143 148 155 186 212 247 247 894
210 244 204 358 286 309 320 392 479 469 457 360 1,765
-148 -178 -146 -289 -213 -230 -248 -313 -366 -250 -200 -1.5 -818
20 21 21 21 21 22 22 21 20 21 20 20 81
-158 -185 -157 -300 -220 -234 -256 -320 -369 -327 -162 -11 -869
0.5 1.0 0.6 0.8 1.0 1.3 0.9 1.2 1.3 1.6 1.5 1.9 6.2
-159 -186 -157 -301 -221 -236 -257 -322 -370 -328 -164 -13 -875
-137 -163 -134 -277 -196 -212 -233 -297 -346 -302 -136 14 -770

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?